Valuation: Zoetis Inc.

Market Cap 30.15B 26.03B 24.42B 22.24B 41.82B 2,883B 42.4B 286B 112B 1,444B 113B 111B 4,805B P/E 2026 *
13x
P/E 2027 * 11.9x
Enterprise Value 37.27B 32.18B 30.19B 27.5B 51.7B 3,564B 52.42B 354B 139B 1,785B 140B 137B 5,939B EV / Sales 2026 *
4.02x
EV / Sales 2027 * 3.82x
Free-Float
82.35%
Yield 2026 *
2.93%
Yield 2027 * 3.15%
1 day+1.54%
1 week-1.61%
Current month-6.20%
1 month-7.35%
3 months-2.90%
6 months-41.87%
Current year-41.96%
1 week 61.5
Extreme 61.5
65.74
1 month 61.5
Extreme 61.5
69.2
Current year 61.5
Extreme 61.5
114.98
1 year 61.5
Extreme 61.5
137.14
3 years 61.5
Extreme 61.5
185
5 years 61.5
Extreme 61.5
221
10 years 61.5
Extreme 61.5
221
Manager TitleAgeSince
Chief Executive Officer 54 2019-12-31
Director of Finance/CFO 53 2026-08-16
Chief Tech/Sci/R&D Officer 49 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2012-06-30
Director/Board Member 68 2012-12-31
Chairman 73 2013-06-25
Change 5-day change 1-year change 3-year change Capi.($)
-3.20%-1.61% - - 30.15B
-1.11%-2.49%-52.65%-60.08% 30.15B
-0.25%+5.97%+31.46%+106.02% 11.8B
+2.54%-1.28%-18.09%+3.93% 3.87B
-1.05%-1.50%-0.60%+20.07% 3.19B
-0.15%-3.29%+51.29%+36.74% 2.18B
-1.70%-1.70%+11.81%+20.24% 1.94B
+0.79%+1.41%+12.91%+131.64% 1.4B
-1.77%+2.88%-16.99%+4.71% 1.27B
+0.30%-1.05%-12.47%-44.77% 1B
Average -0.09%+0.51%+0.74%+24.28% 6.31B
Weighted average by Cap. +0.14%-0.14%-20.59%-3.80%

Financials

2026 *2027 *
Net sales 9.26B 8B 7.5B 6.83B 12.85B 886B 13.03B 87.95B 34.46B 444B 34.78B 34.02B 1,476B 9.56B 8.25B 7.74B 7.05B 13.26B 914B 13.44B 90.74B 35.56B 458B 35.88B 35.1B 1,523B
Net income 2.36B 2.04B 1.91B 1.74B 3.28B 226B 3.32B 22.42B 8.78B 113B 8.87B 8.67B 376B 2.49B 2.15B 2.01B 1.84B 3.45B 238B 3.5B 23.62B 9.26B 119B 9.34B 9.14B 396B
Net Debt 7.12B 6.15B 5.77B 5.25B 9.88B 681B 10.01B 67.61B 26.49B 341B 26.73B 26.15B 1,135B 6.38B 5.51B 5.17B 4.71B 8.85B 610B 8.97B 60.56B 23.73B 306B 23.95B 23.43B 1,016B
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
26-08-17 €62.28 -3.20% 6,023
26-08-14 €64.34 +0.47% 1,517
26-08-13 €64.04 +2.27% 2,235
26-08-12 €62.62 -3.60% 4,238
26-08-11 €64.96 +2.62% 1,806
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
72.97USD
Average target price
100.94USD
Spread / Average Target
+38.33%

Quarterly revenue - Rate of surprise